• Nikhil Gulati
  • Vanya Dwivedi


Ocular drug delivery system for the treatment of eye diseases has become popular and feasible in the past few years. Improving ocular contact time, enhancing corneal permeability and site specificity are the key points for the optimization of ocular drug delivery. Use of polymers such as ethylene vinyl acetate copolymer can increase the solution viscosity and decrease the drainage of solution, thereby increasing the contact time and its bioavailabilty. There are various types of ocular drug release system such as ocusert, contact lenses, diffusional inserts which falls under the category of non-erodible ocular controlled release system, lacrisert, soluble ocular delivery implant(SODI), minidisc which falls under the category of erodible ocular controlled release system; nanoparticles; liposomes.

Episcleral, intrascleral and suprachoroidal routes have the advantage of bypassing the main barriers to topical drug penetration. This type of delivery system provides a controlled release of drug for a long period of time. This type of delivery system has good patient compliance. Acuvue, lacrisert; biomedics are the most common marketed products of ocular drug delivery system.

Keywords: ocular drug delivery system, bioavailability, ethylene vinyl acetate copolymer; episcleral, intrascleral and suprachoroidal routes of drug delivery; erodible and non erodible ocular controlled release system.


Download data is not yet available.


1. Vyas SP, Khar KR. Targeted and controlled drug delivery system. 1st ed. Delhi: CBS publishers and distributors; 2002.
2. Kumari A, Sharma PK, Garg VK. Advancement in therapy of eye diseases. Journal of Adv Pharma Tech. and Res [internet]. 2010 Nov; [cited 2014 July 12]; 1(3):291-6. Available from:
3. Remington G. The science and practice of pharmacy.1st ed. Pennsylvania: Mack publication Company: 1563-1567.
4. Tangri P, khurana S. Basis of ocular drug delivery system. Int J Pharm Biomed Res [Internet]. 2011 Oct [cited 2014 Jul 05]; 2(4):1540-1541.Available from:
5. Patel V, Agarwal YK, Current status and advanced approaches in ocular drug delivery system. J Global Trends Pharm. Sci [internet]. 2011 Apr [cited 2014 July 14]; 2(2):131-48. Available from :
6. Rathore KS. Review on insitu-gelling opthalmic drug delivery system. Int J Pharm Pharm Sci [Internet]. 2010 Aug [cited 2014 Jul 10]; 2(4):30-4. Available from:
167 Views | 238 Downloads
How to Cite
Gulati, N., and V. Dwivedi. “REVIEW ON OCULAR DRUG DELIVERY SYSTEM AND ITS DEVICES”. International Journal of Drug Regulatory Affairs, Vol. 2, no. 3, Feb. 2018, pp. 79-82, doi:10.22270/ijdra.v2i3.145.